Paul Smart
About Paul Smart
Paul Smart is the Associate Medical Affairs Director, Immuno-Oncology at BeiGene in Sydney, with over 20 years of experience in the pharmaceutical industry, focusing on oncology and haematology.
Current Position at BeiGene
Paul Smart currently holds the position of Associate Medical Affairs Director, Immuno-Oncology, at BeiGene. Based in Sydney, New South Wales, Australia, he oversees medical affairs activities related to immuno-oncology. His role involves strategic planning, scientific support, and interaction with key stakeholders to advance BeiGene's portfolio in this important therapeutic area.
Experience at The Janssen Pharmaceutical Companies of Johnson & Johnson
Paul Smart worked as a Senior Medical Advisor, Haematology, at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2020 to 2021. In this role, he was based in Sydney, New South Wales, Australia, and provided strategic medical advice and support for the company's haematology products. His responsibilities included clinical data analysis, advisory board management, and the development of medical strategies for product launches.
Professional Tenure at Actelion
From 2019 to 2020, Paul Smart worked as a Medical Advisor at Actelion in Sydney, Australia. During his tenure, he provided medical and scientific support for Actelion's portfolio, contributing to the company's efforts in bringing innovative treatments to the market. His role required a deep understanding of clinical research and medical communications, ensuring the accurate dissemination of scientific information.
Career at AstraZeneca
Paul Smart spent three years at AstraZeneca, from 2015 to 2018, in the role of Senior Medical Manager - Oncology. Based in Sydney, Australia, he played a pivotal role in the launch and management of oncology therapies. His work involved close collaboration with clinical teams, regulatory authorities, and marketing departments to ensure the successful introduction of new treatments in the oncology space.
Educational Background
Paul Smart pursued his higher education at Nottingham Trent University, where he studied Applied Biology and achieved a Bachelor of Science (BSc) degree. This academic foundation provided him with the scientific knowledge and analytical skills required for his extensive career in the pharmaceutical industry, particularly in oncology and haematology.